HOUSTON, NOVEMBER 20, 2025 ― At The University of Texas MD Anderson Cancer Center , research breakthroughs are made possible through seamless ...
Christopher DeVries, a business owner and longtime member of the Texas City-La Marque Chamber of Commerce, died Nov. 13 while ...
Bayer’s Hyrnuo gets US FDA accelerated approval to treat patients with previously treated advanced HER2-mutant NSCLC: Berlin Friday, November 21, 2025, 11:00 Hrs [IST] Following ...
Sevabertinib produced “robust and durable” responses in patients with HER2-mutant NSCLC, whether they were previously treated or untreated in the advanced setting, according to Xiuning Le, MD, PhD.
Researchers at Tulane University, with a team of colleagues from eight other universities, have discovered a new nerve cell ...
Researchers from The University of Texas at Dallas' Center for Advanced Pain Studies (CAPS) and their colleagues have made a fundamental discovery ...
Researchers at Tulane University, with a team of colleagues from eight other universities, have discovered a new nerve cell signaling mechanism that could transform our understanding of pain and lead ...
In the complex landscape of women’s health, ovarian cancer often carries a shroud of misconception, frequently labeled a ...
A newly discovered neuron-released enzyme could transform pain treatment and reveal deeper secrets of how the brain learns.